Serum autotaxin levels are correlated with hepatic fibrosis and ballooning in patients with non-alcoholic fatty liver disease

被引:0
|
作者
Naoyuki Fujimori [1 ]
Takeji Umemura [1 ]
Takefumi Kimura [1 ]
Naoki Tanaka [2 ,3 ]
Ayumi Sugiura [1 ]
Tomoo Yamazaki [1 ]
Satoru Joshita [1 ]
Michiharu Komatsu [1 ]
Yoko Usami [4 ]
Kenji Sano [4 ]
Koji Igarashi [5 ]
Akihiro Matsumoto [1 ]
Eiji Tanaka [1 ]
机构
[1] Department of Internal Medicine,Division of Gastroenterology,Shinshu University School of Medicine
[2] Department of Metabolic Regulation,Shinshu University Graduate School of Medicine
[3] Research Center for Agricultural Food Industry,Shinshu University
[4] Department of Laboratory Medicine,Shinshu University Hospital
[5] Bioscience Division,TOSOH Corporation
关键词
Autotaxin; Non-alcoholic fatty liver disease; Fibrosis; Ballooning;
D O I
暂无
中图分类号
R575.5 [肝代谢障碍];
学科分类号
1002 ; 100201 ;
摘要
AIM To examine the relationship between serum autotaxin(ATX) concentrations and clinicopathological findings in non-alcoholic fatty liver disease(NAFLD) patients.METHODS One hundred eighty-six NAFLD patients who had undergone liver biopsy between 2008 and 2017 were retrospectively enrolled.Serum samples were collected at the time of biopsy and ATX was measured by enzyme immunoassays.Sera obtained from 160 healthy,nonobese individuals were used as controls.Histological findings were graded according to an NAFLD scoring system and correlations with serum ATX were calculated by Spearman’s test.Diagnostic accuracy was evaluated using the area under the receiver operating characteristic curve(AUC).Cut-off values were identified by the Youden index,and the nearest clinically applicable value to the cutoff was considered the optimal threshold for clinical convenience.RESULTS Serum ATX levels were significantly higher in NAFLD patients than in controls(0.86 mg/L vs 0.76 mg/L,P < 0.001) and correlated significantly with ballooning score and fibrosis stage(r = 0.36,P < 0.001 and r = 0.45,P < 0.001,respectively).Such tendencies were stronger in female patients.There were no remarkable relationships between ATX and serum alanine aminotransferase,lipid profiles,or steatosis scores.The AUC values of ATX for predicting the presence of fibrosis(≥ F1),significant fibrosis(≥ F2),severe fibrosis(≥ F3),and cirrhosis(F4),were all more than 0.70 in respective analyses.CONCLUSION Serum ATX levels may at least partially reflect histological severity in NAFLD.
引用
收藏
页码:1239 / 1249
页数:11
相关论文
共 50 条
  • [41] DIABETES IS THE STRONGEST RISK FACTOR OF HEPATIC FIBROSIS IN LEAN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
    Park, Huiyul
    Yoon, Eileen
    Jun, Dae Won
    Ahn, Sang Bong
    Kang, Bo-Kyeong
    Kim, Mimi
    Lee, Chul-Min
    An, Ji Hyun
    Sohn, Joo Hyun
    HEPATOLOGY, 2021, 74 : 1003A - 1004A
  • [42] Can FibroMeter VCTE™ be useful for detecting hepatic fibrosis in patients with non-alcoholic fatty liver disease?
    Dincses, Elif
    Yilmaz, Yusuf
    HEPATOLOGY, 2015, 62 : 1270A - 1270A
  • [43] Diabetes is the strongest risk factor of hepatic fibrosis in lean patients with non-alcoholic fatty liver disease
    Park, Huiyul
    Yoon, Eileen L.
    Cho, Seon
    Jun, Dae Won
    Nah, Eun-Hee
    GUT, 2022, 71 (05) : 1035 - 1036
  • [44] Fructose intake is not associated to the risk of hepatic fibrosis in patients with Non-Alcoholic Fatty Liver Disease (NAFLD)
    Zhu, Feiyan
    Li, Xiaofei
    CLINICAL NUTRITION, 2021, 40 (06) : 3827 - 3827
  • [45] The risk of atrial fibrillation in patients with non-alcoholic fatty liver disease and a high hepatic fibrosis index
    Hyo Eun Park
    Heesun Lee
    Su-Yeon Choi
    Hua Sun Kim
    Goh Eun Chung
    Scientific Reports, 10
  • [46] REDUCED HEPATIC MITOCHONDRIAL FATTY ACID OXIDATION IN VETERANS WITH NON-ALCOHOLIC FATTY LIVER DISEASE AND HEPATIC FIBROSIS
    Sharma, Neal
    HEPATOLOGY, 2021, 74 : 1121A - 1122A
  • [47] The risk of atrial fibrillation in patients with non-alcoholic fatty liver disease and a high hepatic fibrosis index
    Park, Hyo Eun
    Lee, Heesun
    Choi, Su-Yeon
    Kim, Hua Sun
    Chung, Goh Eun
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [48] Diabetes Mellitus Increases the Risk of Significant Hepatic Fibrosis in Patients With Non-alcoholic Fatty Liver Disease
    Chhabra, Sandeep
    Singh, Arshdeep
    Mehta, Varun
    Kaur, Amninder
    Bansal, Namita
    Sood, Ajit
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2022, 12 (02) : 409 - 416
  • [49] Oral Fungal and Bacterial Proportions in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) and Hepatic Fibrosis
    Mehta, Rohini
    Stoddard, Sasha
    Estep, James M.
    Golabi, Pegah
    Paik, James
    Allawi, Hussain
    Lam, Brian P.
    Birerdinc, Aybike
    Keo, Wisna'Odom
    Mann, Puneetinder
    Schneider, Ingrid
    Younossi, Zobair M.
    HEPATOLOGY, 2018, 68 : 145A - 145A
  • [50] Use of Insulin and Sulfonylurea Is Associated With Hepatic Fibrosis in Diabetic Patients With Non-Alcoholic Fatty Liver Disease
    Goh, George Boon-Bee
    Dasarathy, Jaividhya
    Pagadala, Mangesh R.
    Unalp, Aynur
    Hawkins, Carol
    Sargent, Ruth
    Sourianarayanane, Achuthan
    Pai, Rish
    Yerian, Lisa
    Khiyami, Amer
    Dasarathy, Srinivasan
    McCullough, Arthur J.
    GASTROENTEROLOGY, 2014, 146 (05) : S948 - S948